首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Assessment of disease risk by quantitative determination of epimutation in normal tissues
摘要
申请公布号
AU2004281299(B2)
申请公布日期
2010.11.18
申请号
AU20040281299
申请日期
2004.10.20
申请人
ST VINCENT'S HOSPITAL SYDNEY LIMITED;VICTOR CHANG CARDIAC RESEARCH INSTITUTE LIMITED
发明人
CATHERINE MARY SUTER;ROBYN LYNNE WARD;DAVID I. K. MARTIN
分类号
C12Q1/68
主分类号
C12Q1/68
代理机构
代理人
主权项
地址
您可能感兴趣的专利
METHOD AND APPARATUS FOR DETECTING AND REMOVING AIRBORNE MICROBE IN BUILDING SPACE
NEUTRAL CONTROLLER FOR AUTOMATIC TRANSMISSION FOR VEHICLE
COATED CUTTING TOOL INSERT
ELECTRONIC SYSTEM AND OPERATING METHOD OF ELECTRONIC SYSTEM
IMAGE FORMATION APPARATUS
METHOD OF MANUFACTURING ORGANIC ELECTROLUMINESCENT PANEL, AND ORGANIC ELECTROLUMINESCENT PANEL
REMOTE LOCK SYSTEM, COMMUNICATION TERMINAL, REMOTE LOCK METHOD, AND SERVER FOR COMMUNICATION NETWORK
PASSWORD INPUT DEVICE
AUTHENTICATION METHOD AND ITS SYSTEM
AUTHENTICATION DEVICE AND AUTHENTICATION METHOD
IMAGE FORMING APPARATUS
OPTICAL SCANNER AND IMAGE FORMING APPARATUS
OPTICAL FIBER WITH PORE
HEATING FLOOR MATERIAL
POLYESTER OR POLYAMIDE CONDUCTIVE YARN AND BRUSH
AGENT FOR DECOMPOSING ORGANIC HALOGEN-CONTAINING COMPOUND
IMAGING ELEMENT
ULTRASONIC PROBE
DEVICE OF LIGHTING LAMP
METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE
